GGrantIndex
Sort

64,565 grants matching drug discovery

Structure, function, and inhibition of the SARS-CoV-2 replication-transcription complex

$638,072
Seth A Darst · Rockefeller University · R01 · FY2021 · AI

Therapy-related leukemia following autologous transplantation for lymphoma

$638,056
Smita Bhatia · Beckman Research Institute/City Of Hope · P50 · FY2020 · CA

Consomic rat panels for pharmacogenomic studies and target identification

$638,031
Steven H Nye · Physiogenix, Inc. · R44 · FY2007 · RR

CPS: Synergy: Collaborative Research: Learning from cells to create transportation infrastructure at the micron scale

$638,000
Murti Salapaka · University Of Minnesota-Twin Cities · · FY2015 · CSE

Drug Dependence Clinical Research Program-Research Support Core

$637,943
Reese T. Jones · University Of California, San Francisco · P30 · FY2017 · DA

Microbial Ecology-Guided Discovery of Antibacterial Drugs

$637,929
Eric W Schmidt · University Of Utah · R01 · FY2023 · AI

Lethal Mutagenesis as an Antiviral Strategy

$637,887
Pennsylvania State University-Univ Park · U01 · FY2004 · AI

Understanding Treatment Response Patterns And Therapy Resistance In IDH-Mutant AML

$637,871
Ann-Kathrin Eisfeld · Ohio State University · R01 · FY2023 · CA

Integrative Analysis of Genomic, Epigenomic and Phenotypic Data for Disease Stratification of Endometriosis

$637,845
Linda C Giudice · University Of California, San Francisco · R01 · FY2016 · HD

Discovery Proteomics Core

$637,827
Tukiet T Lam · Yale University · P30 · FY2019 · DA

Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases

$637,742
Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

Cancer Research Training in Molecular Biology

$637,729
Amy H Bouton · University Of Virginia · T32 · FY2011 · CA

Structure and dynamics of bacterial cell wall synthases

$637,729
Andrew Kruse · Harvard Medical School · R01 · FY2025 · AI

Genetic Predictors of Early Clinical Failure in Diffuse Large B Cell Lymphoma

$637,699
Anne Josephine Novak · Mayo Clinic Rochester · R01 · FY2019 · CA

Kv7.2/7.3 Activators for the Treatment of Epilepsy Disorders

$637,634
Michael Bozik · Knopp Biosciences, Llc · U44 · FY2017 · NS

Novel Antifungals by Engineering the AbA NRPS gene

$637,619
Ake P Elhammer · Aureogen Biosciences, Inc. · R44 · FY2006 · AI

Enabling new translational discoveries using a genomic data-driven nosology

$637,505
Atul J Butte · Stanford University · R01 · FY2014 · GM

Faculty Recruitment in Novel Therapeutic Strategies for Neurodegenerative Disease

$637,500
Raymond J Dingledine · Emory University · P30 · FY2009 · NS

Clinical Core

$637,479
Brian Wigdahl · Temple Univ Of The Commonwealth · P30 · FY2017 · MH

Novel small-molecule therapies for CF

$637,418
Alan S Verkman · University Of California, San Francisco · P30 · FY2021 · DK

Mechanisms and targeting of aberrant Gas activation in myeloid neoplasms

$637,399
Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA

PaSAGE: PAtient Supported Approaches to Gene Editing

$637,291
Megan A. Allyse · Mayo Clinic Jacksonville · R01 · FY2023 · HG

FAST-FNA immune cell profiling in HNSCC

$637,189
Ralph Weissleder · Massachusetts General Hospital · R01 · FY2024 · CA

Small molecule mimetics of Humanin that normalize neuronal p-Akt as novel therapeutics for AD

$637,164
Varghese John · University Of California Los Angeles · R01 · FY2025 · AG

Microbial Ecology-Guided Discovery of Antibacterial Drugs

$637,153
Eric W Schmidt · University Of Utah · R01 · FY2024 · AI